But the large ones have a better case model, have seen as many as 80 PTAB requests denied one after another. Most companies after a few have simply stopped submitting them. Similarly, it's been reported that Ex parte reexaminations are also being reduced, thus eliminating the ability to ever question a patent unless you're willing to spend as much as tens of millions of dollars in a protracted argument. Article 3 procedure that can not only last for years, but obviously means that during that time there is in fact a building potential liability. (04:19–04:35)
CLAIM
Asserts that reductions in ex parte reexaminations limit the ability to challenge patents without significant expense.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
